Growth-hormone-axis research peptides — including CJC-1295 with ipamorelin and tesamorelin — supplied as lyophilised powder for in vitro laboratory work. Every vial is HPLC-tested before release, with published certificates listed by product and strength in the COA library, stocked in Australia and dispatched the same business day when ordered before 12pm AEST. For in vitro research purposes only.
Growth hormone research peptides act on the pituitary through either the GHRH receptor or the ghrelin receptor beside it. This category holds tesamorelin, a synthetic growth-hormone-releasing hormone analogue; ipamorelin, a five-amino-acid ghrelin receptor agonist; and the CJC-1295 (no DAC) + Ipamorelin blend, which pairs both routes in one vial. Research material, listed in Australia for in vitro study.
Related guides: Peptide Types, Categories and Blends · Tesamorelin: What It Is and Who the Trials Studied · CJC-1295 With DAC vs No DAC: What Is the Difference?
CJC-1295 (no DAC) + Ipamorelin can be ordered in Australia from Australian Research Peptides, two peptides freeze-dried together into a single 10 mg vial that works one gland from two…
Tesamorelin is stocked in Australia by Australian Research Peptides as 10 mg of freeze-dried powder — the full 44-amino-acid growth-hormone-releasing hormone chain with its hex-3-enoyl…
Ipamorelin tells the pituitary to release growth hormone, and Australian Research Peptides supplies it within Australia as a sealed 10 mg vial of freeze-dried powder, five amino acids long…
Choose by the pathway the protocol needs. Tesamorelin and CJC-1295 act as growth-hormone-releasing-hormone analogues; ipamorelin is a ghrelin receptor agonist. The CJC-1295 (no DAC) + Ipamorelin listing combines both routes in one vial rather than being a third pathway.
| Compound | Vial strengths listed | Studied in relation to |
|---|---|---|
| CJC-1295 (no DAC) + Ipamorelin | 10 mg | growth hormone research |
| Tesamorelin | 10 mg | growth hormone and visceral fat research |
| Ipamorelin | 10 mg | growth hormone research |